Risvutatug Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2508; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The latest biotech product designed to revolutionize the field of biosimilars. This cutting-edge product is a highly purified and recombinant version of the therapeutic target Risvutatug, offering researchers a reliable and cost-effective alternative to traditional treatments.
Risvutatug Biosimilar – Research Grade is a biosimilar of the naturally occurring protein Risvutatug, which plays a crucial role in regulating cellular growth and differentiation. This biosimilar is produced using advanced biotechnology techniques, ensuring a high level of purity and consistency.
Risvutatug Biosimilar – Research Grade has a wide range of potential applications in the field of biotechnology. It can be used in cell culture studies to investigate the effects of Risvutatug on cellular processes, as well as in drug development and testing.
Researchers can use Risvutatug Biosimilar – Research Grade in various experimental settings to explore its potential therapeutic benefits. Some potential use cases include studying the role of Risvutatug in cancer cell growth and proliferation, investigating its effects on immune system function, and examining its potential for treating autoimmune disorders.
With its high purity and reliable consistency, Risvutatug Biosimilar – Research Grade is a valuable tool for researchers looking to advance their understanding of Risvutatug and its potential applications.
Risvutatug Biosimilar – Research Grade is a recombinant version of the therapeutic target Risvutatug, a protein essential for regulating cellular growth and differentiation.
This biosimilar is a cost-effective and reliable alternative for traditional treatments, making it a valuable tool for cell culture studies, drug development, and testing.
Explore the potential therapeutic benefits of Risvutatug with Risvutatug Biosimilar – Research Grade. Use it in various experimental settings to study its effects on cancer cell growth, immune system function, and autoimmune disorders.
Upgrade your research with Risvutatug Biosimilar – Research Grade and unlock new insights into this vital protein.
ProteoGenix catalogue number PX-TA2508. For research use only.
Target: Risvutatug Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE; Buffer: 0.01 M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
